finance Archives

Health Tech Mohana Ravindranath and Mario Aguilar

Amazon launches new prescribing venture, Google tests search in health care, & Maven’s $90M round

Insurance Tara Bannow

With VillageMD investment, Cigna bets on value-based care for a younger, healthier crowd

Biotech Allison DeAngelis and Kate Sheridan

Boom and bust: Whose biotech VC assets have grown and shrunk the most?

Business Bob Herman

Unexpected troubles hit large medical billing firm R1 RCM, part-owned by Ascension

Biotech Matthew Herper and Allison DeAngelis

Josh Bilenker’s last biotech sold for $8 billion. His next one is cloaked in mystery but loaded with money

Health Tech Mohana Ravindranath, Katie Palmer, Mario Aguilar and Casey Ross

The Q4 health tech tracker: 17 key industry events and milestones to watch

Politics Bob Herman

Get a Ph.D. in health policy — from a single Powerpoint slide

Biotech Allison DeAngelis

Bayer’s venture arm ramps up, seeking to invest $1.3 billion

Business Bob Herman

Envision Healthcare teeters on the brink of bankruptcy

Health Care Inc. Bob Herman

A teaching hospital payout, Humana flirts with Wall Street, and new dialysis incentives

Biotech Allison DeAngelis

Medical pioneers team up to launch new cell therapy biotech

Health Care Inc. Bob Herman

Raising a RUC-kus, Blues’ antitrust deal appealed, & a UAE deal

Biotech Allison DeAngelis

Once a small player among biotech VCs, Mubadala Capital Ventures is punching above its weight

Business Bob Herman

As medical device companies look to snap up Medicare dollars, potential conflicts lurk

Biotech Kate Sheridan

OrbiMed tumbles from the top of STAT’s biotech venture capital performance ranking

Hospitals Bob Herman

Hospitals wrangle billions in FEMA funding to offset Covid costs

Exclusive Allison DeAngelis

Ex-Google CEO’s VC firm brings in hype-busting researcher to expand its biotech investments

Hospitals Tara Bannow

Hospital mergers that dodge antitrust scrutiny lead to dramatically higher prices, study finds

Insurance Bob Herman

Bright Health Group heads toward insolvency as it rushes to raise more cash

Health Care Inc. Bob Herman

Private equity’s latest fixation & the ACA subsidy spigot

A STAT Investigation Tara Bannow

The private equity firms, like Blackstone and KKR, behind 8 of the biggest names in autism therapy

Health Tech Bob Herman and Katie Palmer

One Medical’s dueling offers from Amazon and CVS signal a start to health tech bidding wars

Health Tech Mohana Ravindranath

Teladoc’s earnings point to potential threats to the telehealth industry

Pharmalot Ed Silverman

FDA’s decision to review a Biogen ALS drug is met with skepticism and uncertainty on Wall Street

Biotech Allison DeAngelis

finance

Most Read

Viatris executive is charged with insider trading scheme involving a friend and former colleague

Jeff Jonas leaves Sage Therapeutics to launch biotech incubator

Andreessen Horowitz partners with rural health system to give its companies a go-to pilot site

Talkspace names a new CEO as its stock price continues to struggle

Medicare’s midterm punts, MA marketing schemes, and a closer look at the Abiomed deal

Private equity’s Welsh Carson, casting itself as a noble force, relentlessly pursues profits in health care

Allocate opioid settlement dollars to real addiction-ending solutions

Biotech’s newest odd couple: A pharma insider and a music maven launch a health care VC

All Coverage

Amazon launches new prescribing venture, Google tests search in health care, & Maven’s $90M round

With VillageMD investment, Cigna bets on value-based care for a younger, healthier crowd

Boom and bust: Whose biotech VC assets have grown and shrunk the most?

Unexpected troubles hit large medical billing firm R1 RCM, part-owned by Ascension

Josh Bilenker’s last biotech sold for $8 billion. His next one is cloaked in mystery but loaded with money

The Q4 health tech tracker: 17 key industry events and milestones to watch

Get a Ph.D. in health policy — from a single Powerpoint slide

Bayer’s venture arm ramps up, seeking to invest $1.3 billion

Envision Healthcare teeters on the brink of bankruptcy

A teaching hospital payout, Humana flirts with Wall Street, and new dialysis incentives

Medical pioneers team up to launch new cell therapy biotech

Raising a RUC-kus, Blues’ antitrust deal appealed, & a UAE deal

Once a small player among biotech VCs, Mubadala Capital Ventures is punching above its weight

As medical device companies look to snap up Medicare dollars, potential conflicts lurk

OrbiMed tumbles from the top of STAT’s biotech venture capital performance ranking

Hospitals wrangle billions in FEMA funding to offset Covid costs

Ex-Google CEO’s VC firm brings in hype-busting researcher to expand its biotech investments

Hospital mergers that dodge antitrust scrutiny lead to dramatically higher prices, study finds

Bright Health Group heads toward insolvency as it rushes to raise more cash

Private equity’s latest fixation & the ACA subsidy spigot

The private equity firms, like Blackstone and KKR, behind 8 of the biggest names in autism therapy

One Medical’s dueling offers from Amazon and CVS signal a start to health tech bidding wars

Teladoc’s earnings point to potential threats to the telehealth industry

FDA’s decision to review a Biogen ALS drug is met with skepticism and uncertainty on Wall Street

American Cancer Society’s VC arm partners with Third Rock on oncology companies

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day